Marie E. Fallon's most recent trade in Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A was a trade of 13,683 Class A Common Stock done . Disclosure was reported to the exchange on May 1, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 13,683 | 187,026 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 13,683 | 357,645 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 01 May 2023 | 8,073 | 183,010 | - | 1.1 | 9,260 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,750 | 172,500 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,750 | 190,776 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 307 | 50,612 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 307 | 191,083 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 13,684 | 178,018 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 13,684 | 371,328 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 31 Mar 2023 | 8,732 | 173,343 | - | 1.3 | 11,081 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,750 | 181,768 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 3,750 | 176,250 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 307 | 182,075 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Mar 2023 | 307 | 50,919 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2023 | 180,000 | 180,000 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 13,683 | 385,012 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 13,683 | 171,353 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 01 Mar 2023 | 7,326 | 164,334 | - | 1.3 | 9,736 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 307 | 171,660 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 307 | 51,226 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 13,684 | 398,695 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 13,684 | 163,834 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 2.15 per share. | 01 Feb 2023 | 6,470 | 157,670 | - | 2.1 | 13,904 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 306 | 51,533 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 306 | 164,140 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,350 | 157,743 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 15,350 | 412,379 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 1.56 per share. | 03 Jan 2023 | 7,900 | 150,150 | - | 1.6 | 12,292 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 307 | 51,839 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 307 | 158,050 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 13,350 | 148,262 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 13,350 | 427,729 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 1.94 per share. | 01 Dec 2022 | 6,176 | 142,393 | - | 1.9 | 12,000 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 307 | 52,146 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 307 | 148,569 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 13,350 | 441,079 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 13,350 | 140,884 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 2.65 per share. | 01 Nov 2022 | 6,279 | 134,912 | - | 2.6 | 16,608 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 307 | 52,453 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 307 | 141,191 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 06 Oct 2022 | 102,254 | 127,534 | - | 3.3 | 332,326 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 150,000 | 248,894 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2022 | 40,000 | 40,000 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 490,805 | 680,805 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 490,805 | 190,000 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 490,805 | 496,939 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Nov 2021 | 490,805 | 680,805 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 226,376 | 232,510 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 226,376 | 442,161 | - | - | Restricted Stock Units | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 6,134 | 52,760 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 6,134 | 6,134 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 6,134 | 52,760 | - | - | Class B Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Nov 2021 | 6,134 | 6,134 | - | - | Class A Common Stock | |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See Remarks | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 17 Nov 2021 | 2,722 | 494,217 | - | 3.1 | 8,497 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | See remarks | Sale of securities on an exchange or to another person at price $ 3.12 per share. | 17 Nov 2021 | 2,722 | 229,788 | - | 3.1 | 8,497 | Class A Common Stock |
| Ginkgo Bioworks Holdings Inc (Class A) | Marie E. Fallon | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Sep 2021 | 58,894 | 58,894 | - | - | Class B Common Stock |